SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • Abe Y, Odaka M, Inagaki F, Lax I, Schlessinger J, Kohda D. 1998. Disulfide bond structure of human epidermal growth factor receptor. J Biol Chem 273: 1115011157.
  • Ball EMA, Risbridger GP. 2001. Activins as regulators of branching morphogenesis [review]. Dev Biol 238: 112.
  • Bamford RN, Roessler E, Burdine RD, Saplakoglu U, dela Cruz J, Splitt M, Towbin J, Bowers P, Marino B, Schier AF, Shen MM, Muenke M, Casey B. 2000. Loss-of-function mutations in the EGF-CFC gene CFC1 are associated with human left–right laterality defects. Nat Genet 26: 365369.
  • Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, Zako M. 1999. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68: 729777.
  • Bianco C, Kannan S, De Santis M, Seno M, Tang CK, Martinez-Lacaci I, Kim N, Wallace-Jones B, Lippman ME, Ebert AD, Weehselberger C, Salomon DS. 1999. Cripto-1 indirectly stimulates the tyrosine phosphorylation of erb B-4 through a novel receptor. J Biol Chem 274: 86248629.
  • Bianco C, Wechselberger C, Ebert A, Khan NI, Sun YP, Salomon DS. 2001. Identification of Cripto-1 in human milk. Breast Cancer Res Treat 66: 17.
  • Bianco C, Adkins H, Wechselberger C, Seno M, Normanno N, De Luca A, Sun Y, Khan N, Kenney N, Williams K, Sanicola M, Salomon DS. 2002. Cripto-1 activates Nodal and ALK4 dependent and independent signalling pathways in mammary epithelial cells. (In press).
  • Brandt R, Normanno N, Gullick WJ, Lin JH, Harkins R, Scheider D, Jones BW, Ciardiello F, Persico MG, Armenante F, Kim N, Salomon DS. 1994. Identification and biological characterization of an epidermal growth factor-related protein: Cripto-1. J Biol Chem 269: 1732017328.
  • Carraway KL, Price-Schiavi SA, Komatsu M, Jepson S, Perez A, Carraway CA. 2001. Muc4/sialomucin complex in the mammary gland and breast cancer. J Mammary Gland Biol Neoplasia 6: 323337.
  • Chiu JJ, Sgagias MK, Cowan KH. 1996. Interleukin 6 acts as a paracrine growth factor in human mammary carcinoma cell lines. Clin Cancer Res 2: 215221.
  • Ciardello F, Dono R, Kim N, Persico MG, Salomon DS. 1991. Expression of cripto, a novel gene of the epidermal growth factor gene family, leads to in vitro transformation of a normal mouse mammary epithelium cell line. Cancer Res 51: 10511054.
  • Ciccodicola A, Dono R, Obici S, Simeone A, Zollo M, Persico MG. 1989. Molecular characterization of a gene of the ‘EGF family’ expressed in undifferentiated human NTERA2 teratocarcinoma cells. EMBO J 8: 19871991.
  • Colas JF, Schoenwolf GC. 2000. Subtractive hybridization identifies chick-cripto, a novel EGF-CFC ortholog expressed during gastrulation, neurulation and early cardiogenesis. Gene 255: 205217.
  • De Luca A, Casamassimi A, Selvam MP, Losito S, Ciardiello F, Agrawal S, Salomon DS, Normanno N. 1999. EGF-related peptides are involved in the proliferation and survival of MDA-MB-468 human breast carcinoma cells. Int J Cancer 80: 589594.
  • De Luca A, Arra C, D'Antonio A, Casamassimi A, Losito S, Ferraro P, Ciardiello F, Salomon DS, Normanno N. 2000. Simultaneous blockage of different EGF-like growth factors results in efficient growth inhibition of human colon carcinoma xenografts. Oncogene 19: 58635871.
  • De Santis ML, Kannan S, Smith GH, Seno M, Bianco C, Kim N, Martinez-Lacaci I, Wallace-Jones B, Salomon DS. 1997. Cripto-1 inhibits beta-casein expression in mammary epithelial cells through a p21ras-and phosphatidylinositol 3′-kinase-dependent pathway. Cell Growth Differ 8: 12571266.
  • De Santis ML, Martinez-Lacaci I, Bianco C, Seno M, Wallace-Jones B, Kim N, Ebert A, Wechselberger C, Salomon DS. 2000. Cripto-1 induces apoptosis in HC-11 mouse mammary epithelial cells. Cell Death Differ 7: 189196.
  • Delehedde M, Lyon M, Sergeant N, Rahmoune H, Fernig DG. 2001. Proteoglycans: Pericellular and cell surface multireceptors that integrate external stimuli in the mammary gland. J Mammary Gland Biol Neoplasia 6: 253273.
  • Ding J, Yang Y, Yan Y-T, Chan A, Desai N, Wynshaw-Boris A, Shen MM. 1998. Cripto is required for correct orientation of the anterior–posterior axis in the mouse embryo. Nature 395: 702707.
  • Dono R, Montuori N, Rocchi M, De Ponti-Zilli L, Ciccodicola A, Persico MG. 1991. Isolation and characterization of the CRIPTO autosomal gene and its X-linked related sequence. Am J Hum Genet 49: 555565.
  • Dono R, Scalera L, Pacifico F, Acampora D, Persico MG, Simeone A. 1993. The murine cripto gene: Expression during mesoderm induction and early heart morphogenesis. Development 118: 11571168.
  • Douglas AM, Goss GA, Sutherland RL, Hilton DJ, Berndt MC, Nicola NA, Begley CG. 1997. Expression and function of members of the cytokine receptor superfamily on breast cancer cells. Oncogene 14: 661669.
  • Ebert AD, Wechselberger C, Frank S, Wallace-Jones B, Seno M, Martinez-Lacaci I, Bianco C, De Santis M, Weitzel HK, Salomon DS. 1999. Cripto-1 induces phosphatidylinositol 3′-kinase-dependent phosphorylation of AKT and glycogen synthase kinase 3 beta in human cervical carcinoma cells. Cancer Res 59: 45024505.
  • Ebert AD, Wechselberger C, Nees M, Clair T, Schaller G, Martinez-Lacaci I, Wallace-Jones B, Bianco C, Weitzel HK, Salomon DS. 2000. Cripto-1-induced increase in vimentin expression is associated with enhanced migration of human Caski cervical carcinoma cells. Exp Cell Res 257: 223229.
  • Ertoy D, Ayhan A, Sarac E, Karaagaoglu E, Yasui W, Tahara E. 2000. Clinicopathological implication of cripto expression in early stage invasive cervical carcinomas. Eur J Cancer 36: 10021007.
  • Estrov Z, Samal B, Lapushin R, Kellokumpu-Lehtinen P, Sahin AA, Kurzrock R, Talpaz M, Aggarwal BB. 1995. Leukemia inhibitory factor binds to human breast cancer cells and stimulates their proliferation. J Interferon Cytokine Res 15: 905913.
  • Garcia R, Bowman TL, Niu G, Yu H, Minton S, Muro-Cacho CA, Cox CE, Falcone R, Fairclough R, Parsons S, Laudano A, Gazit A, Levitzki A, Kraker A, Jove R. 2001. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 20: 24992513.
  • Gritsman K, Zhang J, Cheng S, Heckscher E, Talbot WS, Schier AF. 1999. The EGF-CFC protein one-eyed pinhead is essential for nodal signaling. Cell 97: 121132.
  • Herrington EE, Ram TG, Salomon DS, Johnson GR, Gullick WJ, Kenney N, Hosick HL. 1997. Expression of epidermal growth factor-related proteins in the aged adult mouse mammary gland and their relationship to tumorigenesis. J Cell Physiol 170: 4756.
  • Hirota H, Chen J, Betz UAK, Rajewsky K, Gu Y, Ross J, Muller W, Chien KR. 1999. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 97: 189198.
  • Jackson D, Bresnick J, Rosewell I, Crafton T, Poulsom R, Stamp G, Dickson C. 1997. Fibroblast growth factor receptor signalling has a role in lobuloalveolar development of the mammary gland. J Cell Sci 110: 12611268.
  • Johnson SE, Rothstein JL, Knowles BB. 1994. Expression of epidermal growth factor family gene members in early mouse development. Dev Dyn 201: 216226.
  • Jones FE, Welte T, Fu XY, Stern DF. 1999. ErbB4 signaling in the mammary gland is required for lobuloalveolar development and Stat5 activation during lactation. J Cell Biol 147: 7788.
  • Kannan S, De Santis M, Lohmeyer M, Riese DJ, Smith GH, Hynes N, Seno M, Brandt R, Bianco C, Persico G, Kenney N, Normanno N, Martinez-Lacaci I, Ciardello F, Stern DF, Gullick WJ, Salomon DS. 1997. Cripto enhances the tyrosine phosphorylation of Shc and activates mitogen-activated protein kinase (MAPK) in mammary epithelial cells. J Biol Chem 272: 33303335.
  • Kenney NJ, Huang RP, Johnson GR, Wu JX, Okamura D, Matheny W, Kordon E, Gullick WJ, Plowman G, Smith GH, Salomon DS, Adamson ED. 1995. Detection and location of amphiregulin and Cripto-1 expression in the developing postnatal mouse mammary gland. Mol Reprod Dev 41: 277286.
  • Kenney NJ, Smith GH, Maroulakou IG, Green JH, Muller WJ, Callahan R, Salomon DS, Dickson RB. 1996. Detection of amphiregulin and Cripto-1 in mammary tumors from transgenic mice. Mol Carcinog 15: 4456.
  • Kinoshita N, Minshull J, Kirschner MW. 1995. The identification of two novel ligands of the FGF receptor by a yeast screening method and their activity in Xenopus development. Cell 83: 621630.
  • Kintner RL, Hosick HL. 1998. Reduction of Cripto-1 expression by a hammerhead-shaped RNA molecule results from inhibition of translation rather than mRNA cleavage. Biochem Biophys Res Commun 245: 774779.
  • Kodama H, Fukuda K, Pan J, Makino S, Baba A, Hori S, Ogawa S. 1997. Leukemia inhibitor factor, a potent cardiac hypertrophic cytokine, activates the JAK/STAT pathway in rat cardiomyocytes. Circ Res 81: 656663.
  • Kouhara H, Hadari YR, Spivak-Kroizman T, Schilling J, Bar-Sagi D, Lax I, Schlessinger J. 1997. A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell 89: 693702.
  • Kumar A, Novoselov V, Celeste AJ, Wolfman NM, ten Dijke P, Kuehn MR. 2001. Nodal signaling uses activin and transforming growth factor-beta receptor-regulated Smads. J Biol Chem 276: 656661.
  • Kusakabe M, Masuyama N, Hanafusa H, Nishida E. 2001. Xenopus FRS2 is involved in early embryogenesis in cooperation with the Src family kinase Laloo. EMBO Rep 2: 727735.
  • Li Y, Ren J, Yu W, Li Q, Kuwahara H, Yin L, Carraway KL 3rd, Kufe D. 2001. The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin. J Biol Chem 276: 3523935242.
  • Liguori G, Tucci M, Montuori N, Dono R, Lago CT, Pacifico F, Armenante F, Persico MG. 1996. Characterization of the mouse Tdgf1 gene and Tdgf pseudogenes. Mamm Genome 7: 344348.
  • Lohmeyer M, Harrison PM, Kannan S, DeSantis M, O'Reilly NJ, Sternberg MJ, Salomon DS, Gullick WJ. 1997. Chemical synthesis, structural modeling, and biological activity of the epidermal growth factor-like domain of human cripto. Biochemistry 36: 38373845.
  • Medina D, Oborn CJ, Kittrell FS, Ullrich RL. 1986. Properties of mouse mammary epithelial cell lines characterized by in vivo transplantation and in vitro immunocytochemical methods. J Natl Cancer Inst 76: 11431156.
  • Minchiotti G, Parisi S, Liguori G, Signore M, Lania G, Adamson ED, Lago CT, Persico GM. 2000. Membrane-anchorage of Cripto protein by glycosylphosphatidylinositol and its distribution during early mouse development. Mech Dev 90: 133142.
  • Minchiotti G, Manco G, Parisi S, Lago C, Rosa F, Persico G. 2001. Structure-function analysis of the EGF-CFC family member Cripto identifies residues essential for nodal signalling. Development 128: 45014510.
  • Niemeyer CC, Persico MG, Adamson ED. 1998. Cripto: Roles in mammary cell growth, survival, differentiation and transformation. Cell Death Differ 5: 440449.
  • Niemeyer CC, Spencer-Dene B, Wu J-X, Adamson ED. 1999. Preneoplastic mammary tumor markers: Cripto and Amphiregulin are overexpressed in hyperplastic stages of tumor progression in transgenic mice. Int J Cancer 81: 588591.
  • Normanno N, Ciardiello F, Brandt R, Salomon DS. 1994. Epidermal growth factor-related peptides in the pathogenesis of human breast cancer. Breast Cancer Res Treat 29: 1127.
  • Normanno N, Kim N, Wen D, Smith K, Harris AL, Plowman G, Colletta G, Ciardiello F, Salomon DS. 1995. Expression of messenger RNA for amphiregulin, heregulin, and cripto-1, three new members of the epidermal growth factor family, in human breast carcinomas. Breast Cancer Res Treat 35: 293297.
  • Normanno N, Bianco C, De Luca A, Salomon DS. 2001. The role of EGF-related peptides in tumor growth. Front Biosci 6: D685D707.
  • Ong SH, Guy GR, Hadari YR, Laks S, Gotoh N, Schlessinger J, Lax I. 2000. FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors. Mol Cell Biol 20: 979989.
  • Panico L, D'Antonio A, Salvatore G, Mezza E, Tortora G, De Laurentiis M, De Placido S, Giordano T, Merino M, Salomon DS, Mullick WJ, Pettinato G, Schnitt SJ, Bianco AR, Ciardiello F. 1996. Differential immunohistochemical detection of transforming growth factor alpha, amphiregulin and CRIPTO in human normal and malignant breast tissues. Int J Cancer 65: 5156.
  • Ponting CP, Russell RB. 2000. Identification of distant homologues of fibroblast growth factors suggests a common ancestor for all beta-trefoil proteins. J Mol Biol 302: 10411047.
  • Reissmann E, Jornvall H, Blokzijl A, Andersson O, Chang C, Minchiotti G, Persico MG, Ibanez CF, Brivanlou AH. 2001. The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development. Genes Dev 15: 20102022.
  • Robinson CJ, Stringer SE. 2001. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J Cell Sci 114: 853865.
  • Saccone S, Rapisarda A, Motta S, Dono R, Persico GM, Della Valle G. 1995. Regional localization of the human EGF-like growth factor CRIPTO gene (TDGF-1) to chromosome 3p21. Hum Genet 95: 229230.
  • Salomon DS, Bianco C, De Santis M. 1999. Cripto: A novel epidermal growth factor (EGF)-related peptide in mammary gland development and neoplasia [review]. Bioessays 21(1): 6170.
  • Salomon DS, Bianco C, Ebert AD, Khan NI, De Santis M, Normanno N, Wechselberger C, Seno M, Williams K, Sanicola M, Foley S, Gullick WJ, Persico G. 2000. The EGF-CFC family: Novel epidermal growth factor-related proteins in development and cancer. Endocr Relat Cancer 7: 199226.
  • Sariola H. 2001. The neurotrophic factors in non-neuronal tissues. Cell Mol Life Sci 58: 10611066.
  • Schier AF. 2001. Axis formation and patterning in zebrafish. Curr Opin Genet Dev 11: 393404.
  • Schier AF, Shen MM. 2000. Nodal signalling in vertebrate development. Nature 403: 385389.
  • Schiffer SG, Foley S, Kaffashan A, Hronowski X, Zichittella A, Yeo CY, Miatkowski K, Adkins HB, Damon B, Whitman M, Sanicola M, Williams KP. 2001. Fucosylation of Cripto is required for its ability to facilitate Nodal signaling. J Biol Chem 276: 3776937778.
  • Shen MM, Schier AF. 2000. The EGF-CFC gene family in vertebrate development. Trends Genet 16: 303309.
  • Shen MM, Wang H, Leder P. 1997. A differential display strategy identifies Cryptic, a novel EGF-related gene expressed in the axial and lateral mesoderm during mouse gastrulation. Development 124: 429442.
  • Sheng Z, Wu K, Carraway KL, Fregien N. 1992. Molecular cloning of the transmembrane component of the 13762 mammary adenocarcinoma sialomucin complex. A new member of the epidermal growth factor superfamily. J Biol Chem 267: 1634116346.
  • Sherblom AP, Carraway KL. 1980. A complex of two cell surface glycoproteins from ascites mammary adenocarcinoma cells. J Biol Chem 255: 1205112059.
  • Wechselberger C, Ebert AD, Bianco C, Khan NI, Sun Y, Wallace-Jones B, Montesano R, Salomon DS. 2001. Cripto-1 enhances migration and branching morphogenesis of mouse mammary epithelial cells. Exp Cell Res 266: 95105.
  • Wollert KC, Chien KR. 1997. Cardiotrophin-1 and the role of gp130-dependent signaling pathways in cardiac growth and development [review] [98 refs]. J Mol Med 75(7): 492501.
  • Xu C, Liguori G, Adamson ED, Persico MG. 1998. Cardiac differentiation is blocked in embryonic stem cells lacking Cripto-1. Dev Biol 196: 237247.
  • Xu C, Liguori G, Persico MG, Adamson ED. 1999. Abrogation of the Cripto gene in mouse leads to failure of post-gastrulation morphogensis and lack of differentiation of cardiomyocytes. Development 126: 483494.
  • Yeo C, Whitman M. 2001. Nodal signals to Smads through Cripto-dependent and Cripto-independent mechanisms. Mol Cell 7: 949957.
  • Yoshimura N, Sano H, Hashiramoto A, Yamada R, Nakajima H, Kondo M, Oka T. 1998. The expression and localization of fibroblast growth factor-1 (FGF-1) and FGF receptor-1 (FGFR-1) in human breast cancer. Clin Immunol Immunopathol 89: 2834.
  • Zhang J, Talbot WS, Schier AF. 1998. Positional cloning identifies zebrafish one-eyed pinhead as a permissive EGF-related ligand required during gastrulation. Cell 92: 241251.